Holen Sie sich die Stockscreener-App
0.6459
3.55%
-0.0421
Handel nachbörslich:
.61
-0.0359
-5.56%
Abvc Biopharma Inc Aktie (ABVC) Neueste Nachrichten
ABVC BioPharma announces CFO resignation, CEO steps in as interim By Investing.com - Investing.com Canada
ABVC BioPharma announces CFO resignation, CEO steps in as interim - Investing.com India
ABVC Biopharma Inc On March 5, Leeds Chow Resigns As CFO Of Abvc Biopharma - Marketscreener.com
ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs - Financial Content
ABVC BioPharma's CEO Discusses New Drug Development and AI Integration - ACCESS Newswire
ABVC and BioLite Japan Forge Strategic Alliance to Boost Japanese Biotech Global Expansion - citybuzz -
ABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global Markets - Financial Content
ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025 - Yahoo Finance
Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into Global Dietary Supplements Market of USD 75.35 Billion - Yahoo Finance
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Decline in Short Interest - Defense World
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Down 42.6% in December - Defense World
ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market - Yahoo Finance
AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees - Yahoo Finance
Head to Head Review: ABVC BioPharma (NASDAQ:ABVC) vs. Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World
ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement - Yahoo Finance
ABVC BioPharma and ForSeeCon: An Update on Alliance's Ophthalmology-Related Products - Yahoo Finance
ABVC BioPharma Expands Global Patent Portfolio for ADHD Treatment - Citybuzz
ABVC BioPharma Secures an Additional Patent for ADHD Treatment, in Addition to the Granted U.S. and Australian Patents, Moving Forward to the Global Patent Map of $32.14 Billion Potential Market - Yahoo Finance
Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 148.2% - Defense World
ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21 - The Manila Times
ABVC BioPharma Seeks to Revolutionize Mental Health - GlobeNewswire
ABVCAbvc Biopharma Inc Latest Stock News & Market Updates - StockTitan
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Down 24.2% in November - Defense World
ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners - The Manila Times
ABVC BioPharma Secures $200,000 in First Cash Licensing - GlobeNewswire
ABVC BioPharma Secures Major Oncology Licensing Deal: $200K Initial Payment, Up to $50M in Future Royalties - StockTitan
Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 79.2% - Defense World
ABVC BioPharma Inc. Reports Operational Profit and Income Growth in Q3 2024 - Defense World
ABVC BioPharma Inc. (ABVC) Quarterly 10-Q Report - Quartzy
ABVC BioPharma Reports First Operational Profit in Q3 2024, Showcasing Significant Financial Improvement - Citybuzz
ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones - The Manila Times
ABVC BioPharma Reports First-Ever Operational Profit, 2,352% Revenue Surge in Q3 | ABVC Stock News - StockTitan
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Increase in Short Interest - Defense World
ABVC BioPharma Enters into Agreement to Exercise Warrants at Reduced Price - Defense World
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb - MSN
ABVC BioPharma secures additional licensing fees - Investing.com
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners - The Manila Times
ABVC BioPharma secures additional licensing fees By Investing.com - Investing.com UK
ABVC BioPharma switches to new independent accounting firm - Investing.com
ABVC BioPharma switches to new independent accounting firm By Investing.com - Investing.com UK
ABVC BioPharma Inc (ABVC) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Financial Analysis: Eledon Pharmaceuticals (NASDAQ:ELDN) & ABVC BioPharma (NASDAQ:ABVC) - Defense World
1832 Asset Management L.P. Has $21.08 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Kayne Anderson Rudnick Investment Management LLC Lowers Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Avidity Biosciences initiated with a Buy at Goldman Sachs - TipRanks
ABB unveils number of investors with maximum and minimum stakes in shares - Trend News Agency
ABB (NYSE:ABBNY) Stock Price Passes Above 200 Day Moving Average of $52.74 - MarketBeat
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):